よむ、つかう、まなぶ。
資料３－２ ヒドロキシエチルデンプン調査結果報告書 (42 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_29975.html |
| 出典情報 | 薬事・食品衛生審議会 薬事分科会医薬品等安全対策部会安全対策調査会（令和4年度第22回 12／27）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
L1
L2
MEDLINE
3497 SEA HYDROXYETHYL STARCH DERIVATIVES+NT/CT
4797 SEA VOLUVEN? OR HES130? OR HES70? OR (HYDROXYETHYL OR HYDROXY(W)ETHYL)(W)STARCH? OR HES(2A)(130?
OR 70?) OR SALINHES? OR HESPAN#
L3 1671969 SEA RANDOMIZED CONTROLLED TRIAL?/DT OR PRAGMATIC CLINICAL TRIAL/DT OR RANDOM
ALLOCATION+NT/CT OR (SINGLE-BLIND METHOD+NT OR DOUBLE-BLIND METHOD+NT)/CT OR (SINGL? OR DOUBLE? OR
TREBL? OR TRIPL?)(W)(BLIND? OR MASK?) OR RANDOM? OR PRAGMATIC?(3W)(STUD? OR TRIAL? OR TEST?) OR
PLACEBO? OR RCT
L4 3260039 SEA COMPARATIVE STUDY/DT OR CONTROLLED CLINICAL TRIAL?/DT OR (CROSS-OVER STUDIES+NT OR
MATCHED-PAIR ANALYSIS+NT)/CT OR (COMPARATIVE? OR COMPARE? OR COMPARIS? OR CONTROLLED OR
CROSS(1W)OVER? OR CROSSOVER? OR MATCH?(W)PAIR)(3A)(STUD? OR TRIAL? OR TEST? OR DRUG? OR EVALUAT? OR
ANALYS?)
L5 242122 SEA (CLINICAL TRIAL, PHASE II OR CLINICAL TRIAL, PHASE III OR CLINICAL TRIAL, PHASE IV)/DT OR
PHASE(1A)(1 OR I OR 1ST OR FIRST OR 2 OR II OR 2ND OR SECOND OR 3 OR III OR 3RD OR THIRD OR 4 OR IV OR FOURTH
OR 4TH)
L6 13341 SEA PHASE1 OR PHASEI OR PHASE2 OR PHASEII OR PHASE3 OR PHASEIII OR PHASE4 OR PHASEIV OR POSTMARKET?
OR POST(1W)MARKET?
L7 107504 SEA INTERVENTION?(3A)(STUD? OR TRIAL? OR TEST?)
L8 2962998 SEA (COHORT STUDIES+NT OR CASE-CONTROL STUDIES+NT)/CT OR COHORT? OR CASE(1W)(CONTROL? OR BASE?
OR COMPAR? OR REFER?)
L9 2841736 SEA OBSERVATIONAL STUDY?/DT OR CROSS-SECTIONAL STUDIES+NT/CT OR (OBSERV? OR
NON(1W)EXPERIMENT? OR NONEXPERIMENT? OR CROSS(1W)SECTION? OR CROSSSECTION? OR LONGITUDINAL? OR
PROSPECTIVE? OR RETROSPECTIVE?)(3A)(STUD? OR TRIAL? OR TEST? OR SURVEY? OR DESIGN? OR RESEARCH? OR
EVALUAT? OR ANALYS?)
L10 1486916 SEA (CLINICAL STUDY OR CLINICAL TRIAL? OR EVALUATION STUDY OR MULTICENTER STUDY OR VALIDATION
STUDY)/DT
L11 2417283 SEA (CLINICAL? OR EVALUAT? OR MULTICENT? OR MULTI(W)CENT? OR LARGE(W)SCALE OR
VALIDATION?)(3A)(STUD? OR TRIAL? OR TEST? OR SURVEY? OR DESIGN? OR RESEARCH? OR EVALUAT? OR ANALYS?)
OR MEGA(W)(STUD? OR TRIAL?) OR MEGASTUD? OR MEGATRIAL?
L12 696 SEA (L1 OR L2) AND (L3 OR L4 OR L5 OR L6 OR L7 OR L8 OR L9 OR L10) AND (20130601-20220617/ED OR 2013060120220617/UP) AND 2013-2022/PY
L13 437 SEA (L12/HUMAN OR (L12 NOT ANIMALS/CT)) NOT REVIEW/DT AND ARTICLE/DT
L14 102949 SEA BLOOD COAGULATION DISORDERS+NT/CT
L15 36018 SEA COAGULAT?(2A)(DISORDER? OR DEFICIEN?) OR COAGULOPATH?
L16 19 SEA L13 AND (L14 OR L15)
D L16 ALL 1-19
42
L2
MEDLINE
3497 SEA HYDROXYETHYL STARCH DERIVATIVES+NT/CT
4797 SEA VOLUVEN? OR HES130? OR HES70? OR (HYDROXYETHYL OR HYDROXY(W)ETHYL)(W)STARCH? OR HES(2A)(130?
OR 70?) OR SALINHES? OR HESPAN#
L3 1671969 SEA RANDOMIZED CONTROLLED TRIAL?/DT OR PRAGMATIC CLINICAL TRIAL/DT OR RANDOM
ALLOCATION+NT/CT OR (SINGLE-BLIND METHOD+NT OR DOUBLE-BLIND METHOD+NT)/CT OR (SINGL? OR DOUBLE? OR
TREBL? OR TRIPL?)(W)(BLIND? OR MASK?) OR RANDOM? OR PRAGMATIC?(3W)(STUD? OR TRIAL? OR TEST?) OR
PLACEBO? OR RCT
L4 3260039 SEA COMPARATIVE STUDY/DT OR CONTROLLED CLINICAL TRIAL?/DT OR (CROSS-OVER STUDIES+NT OR
MATCHED-PAIR ANALYSIS+NT)/CT OR (COMPARATIVE? OR COMPARE? OR COMPARIS? OR CONTROLLED OR
CROSS(1W)OVER? OR CROSSOVER? OR MATCH?(W)PAIR)(3A)(STUD? OR TRIAL? OR TEST? OR DRUG? OR EVALUAT? OR
ANALYS?)
L5 242122 SEA (CLINICAL TRIAL, PHASE II OR CLINICAL TRIAL, PHASE III OR CLINICAL TRIAL, PHASE IV)/DT OR
PHASE(1A)(1 OR I OR 1ST OR FIRST OR 2 OR II OR 2ND OR SECOND OR 3 OR III OR 3RD OR THIRD OR 4 OR IV OR FOURTH
OR 4TH)
L6 13341 SEA PHASE1 OR PHASEI OR PHASE2 OR PHASEII OR PHASE3 OR PHASEIII OR PHASE4 OR PHASEIV OR POSTMARKET?
OR POST(1W)MARKET?
L7 107504 SEA INTERVENTION?(3A)(STUD? OR TRIAL? OR TEST?)
L8 2962998 SEA (COHORT STUDIES+NT OR CASE-CONTROL STUDIES+NT)/CT OR COHORT? OR CASE(1W)(CONTROL? OR BASE?
OR COMPAR? OR REFER?)
L9 2841736 SEA OBSERVATIONAL STUDY?/DT OR CROSS-SECTIONAL STUDIES+NT/CT OR (OBSERV? OR
NON(1W)EXPERIMENT? OR NONEXPERIMENT? OR CROSS(1W)SECTION? OR CROSSSECTION? OR LONGITUDINAL? OR
PROSPECTIVE? OR RETROSPECTIVE?)(3A)(STUD? OR TRIAL? OR TEST? OR SURVEY? OR DESIGN? OR RESEARCH? OR
EVALUAT? OR ANALYS?)
L10 1486916 SEA (CLINICAL STUDY OR CLINICAL TRIAL? OR EVALUATION STUDY OR MULTICENTER STUDY OR VALIDATION
STUDY)/DT
L11 2417283 SEA (CLINICAL? OR EVALUAT? OR MULTICENT? OR MULTI(W)CENT? OR LARGE(W)SCALE OR
VALIDATION?)(3A)(STUD? OR TRIAL? OR TEST? OR SURVEY? OR DESIGN? OR RESEARCH? OR EVALUAT? OR ANALYS?)
OR MEGA(W)(STUD? OR TRIAL?) OR MEGASTUD? OR MEGATRIAL?
L12 696 SEA (L1 OR L2) AND (L3 OR L4 OR L5 OR L6 OR L7 OR L8 OR L9 OR L10) AND (20130601-20220617/ED OR 2013060120220617/UP) AND 2013-2022/PY
L13 437 SEA (L12/HUMAN OR (L12 NOT ANIMALS/CT)) NOT REVIEW/DT AND ARTICLE/DT
L14 102949 SEA BLOOD COAGULATION DISORDERS+NT/CT
L15 36018 SEA COAGULAT?(2A)(DISORDER? OR DEFICIEN?) OR COAGULOPATH?
L16 19 SEA L13 AND (L14 OR L15)
D L16 ALL 1-19
42